Turning to Ruan et al.’s investigation [38], they showed that miR-4429 expression was significantly lower in the serum of NSCLC patients compared to controls and correlated with tumor size, EGFR mutation, lymph node metastasis, and TNM stage. The gene discussed is EGFR; the disease is neoplasm.